Angelo Di Leo cut his research teeth on the first studies that looked for biological markers that could predict which patients respond to what, and he’s never looked back.
Angelo Di Leo: mapping the geography of breast cancer
Marc Beishon
Related Articles
Past events
Rome (Italy), 25-26/11/2016 – Molecular Diagnostics, Genomics and Epigenetics in Clinical Oncology
Impact Factor
Does trastuzumab increase the risk of isolated CNS metastases in patients with breast cancer?
Spotlight on